How much funding has Neurophet raised?

Neurophet has raised $36.5M in total funding, most recently a Extension Round.

Who are Neurophet's investors?

Neurophet's investors include KB Securities.

Where is Neurophet headquartered?

Neurophet is headquartered in Seoul, South Korea.

What industry is Neurophet in?

Neurophet operates in Artificial Intelligence, Healthcare.

How many employees does Neurophet have?

Neurophet has 51-200 employees.

Neurophet

The Pioneer in Brain Frontiers

Seoul, South Korea · Founded 2016 · $36.5M raised

Artificial Intelligence

Healthcare

Headquarters: Seoul
Employees: 51–200
Founded: 2016
Business Model: B2B

Website: neurophet.com
Total Funding: $36.5M
Last Round: $21.5M Extension RoundApr 2026
Rounds: 2

About

Neurophet is a South Korean medical AI company specializing in AI-driven brain imaging analysis solutions that span the full lifecycle of brain disease diagnosis, treatment planning, and monitoring. Its flagship products — including Neurophet AQUA (brain neurodegeneration imaging analysis), Neurophet AQUA AD Plus (Alzheimer's treatment prescription support), and Neurophet SCALE PET (quantitative PET imaging analysis) — are used by hospitals, pharmaceutical companies, and clinical research organizations globally. The company partners with institutions such as the University of Washington Radiology and Nanyang Technological University, and provides imaging core lab services for clinical trials targeting Alzheimer's and Parkinson's disease therapies.

Summary

Neurophet is an Artificial Intelligence company based in Seoul, South Korea, founded in 2016. It has raised $36.5M in total across 2 rounds, most recently a $21.5M Extension Round round in Apr 2026. Investors include KB Securities.